iSpecimen (ISPC) EBIT Margin: 2020-2025
Historic EBIT Margin for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to -2,655.19%.
- iSpecimen's EBIT Margin fell 259113.00% to -2,655.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -361.81%, marking a year-over-year decrease of 26789.00%. This contributed to the annual value of -136.99% for FY2024, which is 2449.00% down from last year.
- As of Q3 2025, iSpecimen's EBIT Margin stood at -2,655.19%, which was down 939.58% from -255.41% recorded in Q2 2025.
- iSpecimen's 5-year EBIT Margin high stood at -31.81% for Q1 2021, and its period low was -2,655.19% during Q3 2025.
- In the last 3 years, iSpecimen's EBIT Margin had a median value of -131.03% in 2024 and averaged -384.41%.
- In the last 5 years, iSpecimen's EBIT Margin soared by 14,299bps in 2024 and then crashed by 259,113bps in 2025.
- Over the past 5 years, iSpecimen's EBIT Margin (Quarterly) stood at -78.26% in 2021, then skyrocketed by 595bps to -72.31% in 2022, then slumped by 3,918bps to -111.49% in 2023, then tumbled by 28,434bps to -395.83% in 2024, then slumped by 259,113bps to -2,655.19% in 2025.
- Its EBIT Margin stands at -2,655.19% for Q3 2025, versus -255.41% for Q2 2025 and -154.93% for Q1 2025.